Marco Meglio, Editor for NeurologyLive, has been with the team since October 2019. Follow him on Twitter @marcomeglio1 or email him at mmeglio@neurologylive.com
Roche’s Crenezumab Fails to Meet End Points in Autosomal Dominant Alzheimer Disease
June 20th 2022In the first NIH-backed study to evaluate an experimental prevention therapy in cognitively unimpaired persons at risk for Alzheimer disease, crenezumab showed small numerical, but not statistically significant differences compared with placebo.
Understanding Treatment Decisions and Differences Between Diroximel Fumarate and Dimethyl Fumarate
June 16th 2022Meghan Garabedian, CRNP, MSN, nurse practitioner at the Penn Neuroscience Center, discussed her presentation at the 2022 CMSC Annual Meeting regarding the patient experience on diroximel fumarate.
The Importance of Sleep Quality for Cognitive Health Throughout the Stages of Menopause
June 15th 2022Galit L. Dunietz, PhD, MPH, assistant professor of neurology, University of Michigan, provided insight on women’s health, menopause cycles, and how sleep can have a direct impact on long-term cognitive health.
Moderate-to-Severe Post-COVID-19 Sleep Disturbances Common, Especially in Black Individuals
June 8th 2022Patients with moderate-severe compared with normal-to-mild sleep disturbances had worse GAD-2 questionnaire scores, PHQ-2 scores, and PROMIS fatigue scores with no difference in age, sex, or hospitalization due to COVID-19.